Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis

Peritoneal Dialysis International

Volumn 19, Issue 6, 1999, Pages 534-539

  Brophy, Donald F ^a   Sowinski, Kevin M ^b   Kraus, Michael A ^c   Moe, Sharon M ^c   Klaunig, James E ^c   Mueller, Bruce A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Creatinine; Dialytic clearance; Gentamicin; Middle molecule; NIPD; Urea; Vancomycin; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; GENTAMICIN; UREA; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; DRUG CLEARANCE; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MOLECULAR WEIGHT; NIGHT; PERITONEAL DIALYSIS; PLASMA CLEARANCE; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; STATISTICAL ANALYSIS;

EID: 0033371934     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900607     Document Type: Article

References (25)

1. Diaz-Buxo JA, Suki WN. Automated peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers, 1994:399-418.
2. Woodrow G, Turney JH, Cook JA, Gibson J, Fletcher S, Stewart AJ, et al. Nocturnal intermittent peritoneal dialysis. Nephrol Dial Transplant 1994; 9:399-403.
3. Flanigan MJ, Pflederer TA, Lim VS. Is 8 hours of nightly peritoneal dialysis enough? ASAIO J 1994; 40:24-6.
4. Ofsthun NJ, Zydney AL. Importance of convection in artificial kidney treatment. Contrib Nephrol 1994; 108:53-70.
5. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers, 1994:69-113.
6. Dahl NV, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, et al. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Ann Pharmacother 1998; 32:1284-9.
7. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
8. Lasricht M, Maher JM, Przemyslaw H, Maher JF. Correlation of peritoneal transport rates with molecular weight: a method for predicting clearances. ASAIO J 1979; 3:107-13.
9. Gotch FA, Keen ML. Kinetic modeling in peritoneal dialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical dialysis. 3rd ed. Norwalk, CT: Appleton and Lange, 1995:343-75.
10. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-9.
11. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48:1946-52.
12. Mahon WA, Ezer JI, Cattran DC. Studies on gentamicin clearance during peritoneal and hemodialysis. Clin Res 1973; 21:1018-22.
13. Paton TW, Manuel MA, Walker SE. Tobramycin disposition in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982; 2:179-81.
14. Matzke GR, Halstenson CE, Blevins RB, Salem NG. Pharmacokinetics of vancomycin during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 23:236.
15. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34:110-16.
16. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34:631-7.
17. Blevins RD, Halstenson CE, Salem NG, Matzke GR. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1984; 25:603-6.
18. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31:173-7.
19. Jusko WJ, Baliah T, Kim KH, Gerbrecht LM, Yaffe SJ. Pharmacokinetics of gentamicin during peritoneal dialysis in children. Kidney Int 1976; 9:430-8.
20. Nielsen HE, Sorensen I, Hansen HE. Peritoneal transport of vancomycin during peritoneal dialysis. Nephron 1979; 24:274-7.
21. Glew RH, Pavuk RA, Shuster A, Alfred HJ. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis. Int J Clin Pharmacol Ther Toxicol 1982; 20:559-63.
22. Indrapasit S, Ukaravichien V, Pummangura C, Kaojaren S. Gentamicin removal during intermittent peritoneal dialysis. Nephron 1986; 44:18-21.
23. Keller E, Reetze P, Schollmeyer P. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis - clinical pharmacokinetic considerations. Clin Pharmacokinet 1990; 18:104-17.
24. Scott MK, Mueller BA, Sowinski KM, Clark WR. Dialyzer dependent changes in solute and water permeability with bleach reprocessing. Am J Kidney Dis 1999; 33:86-97.
25. Ayus JC, Eneas JF, Tong TG, Benowitz NL, Schoenfeld PY, Hadley KL, et al. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin Nephrol 1979; 11:129-32.